Cargando…
PReS-FINAL-2338: Fate of lymphocytes after withdrawal of Tofacitinib treatment
Autores principales: | Tommasini, A, Piscianz, E, Valencic, E, Cuzzoni, E, Decorti, G, Taddio, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043191/ http://dx.doi.org/10.1186/1546-0096-11-S2-P328 |
Ejemplares similares
-
Fate of Lymphocytes after Withdrawal of Tofacitinib Treatment
por: Piscianz, Elisa, et al.
Publicado: (2014) -
PReS-FINAL-2043: Cardiac involvement in juvenile idiopathic arthritis
por: Rossetto, E, et al.
Publicado: (2013) -
PReS-FINAL-2165: Pharmacogenetic determinants of response to methotrexate in juvenile idiopathic arthritis
por: Pastore, S, et al.
Publicado: (2013) -
PReS-FINAL-2220: Cochlear involvement in FMF
por: Keskindemirci, G, et al.
Publicado: (2013) -
PReS-FINAL-2221: An earliest diagnosis of FMF
por: Keskindemirci, G, et al.
Publicado: (2013)